Serenno Medical

Serenno Medical

Serenno Medical, an Israeli Medical Device startup, develops a novel method to predict, identify and avoid common, life-threatening ICU complications such as Acute Kidney Injury – a deadly ICU complication with a yearly estimated death-toll of 300,000 lives in the US alone (tripling mortality risks), and no cure after onset.
Serenno uses a robust, hands-free, low cost, and non-invasive device measuring accurate, ongoing urine output for hospitalized patients. Medical personnel would be able to predict and avoid AKI with no need for massive interventions, significantly reducing LOS and costs. The Serenno Sentinel is showing good results in a multicenter ICU FIH clinical trial and entering a fast-growing $1.5B market tackling an increasingly dangerous problem affecting 19 million people per year.